نتایج جستجو برای: flt3 itd

تعداد نتایج: 4119  

Journal: :Blood 2008
Hyung-Gyoon Kim Kyoko Kojima C Scott Swindle Claudiu V Cotta Yongliang Huo Vishnu Reddy Christopher A Klug

The inversion of chromosome 16 in the inv(16)(p13q22) is one of the most frequent cytogenetic abnormalities observed in acute myeloid leukemia (AML). The inv(16) fuses the core binding factor (CBF) beta subunit with the coiled-coil rod domain of smooth muscle myosin heavy chain (SMMHC). Expression of CBFbeta-SMMHC in mice does not promote AML in the absence of secondary mutations. Patient sampl...

2014
Shuang Qu Bin Liu Xiaoling Guo Hongshun Shi Meifeng Zhou Li Li Shulan Yang Xiuzhen Tong Haihe Wang

BACKGROUND Internal tandem duplication of FMS-like tyrosine kinase (FLT3-ITD) is well known to be involved in acute myeloid leukemia (AML) progression, but FLT3-ITD-negative AML cases account for 70% to 80% of AML, and the mechanisms underlying their pathology remain unclear. This study identifies protein tyrosine phophatase PRL-3 as a key mediator of FLT3-ITD-negative AML. METHODS A total of...

Journal: :Molecular cancer therapeutics 2014
Warren Fiskus Sunil Sharma Jun Qi Bhavin Shah Santhana G T Devaraj Christopher Leveque Bryce P Portier Swaminathan Iyer James E Bradner Kapil N Bhalla

Recently, treatment with bromodomain and extraterminal protein antagonist (BA) such as JQ1 has been shown to inhibit growth and induce apoptosis of human acute myelogenous leukemia (AML) cells, including those expressing FLT3-ITD. Here, we demonstrate that cotreatment with JQ1 and the FLT3 tyrosine kinase inhibitor (TKI) ponatinib or AC220 synergistically induce apoptosis of cultured and primar...

2008
Lars Bullinger Konstanze Döhner Raphael Kranz Christoph Stirner Stefan Fröhling Claudia Scholl Young H. Kim Richard F. Schlenk Robert Tibshirani R. Pollack

Acute myeloid leukemia with normal karyotype (NK-AML) represents a cytogenetic grouping with intermediate prognosis but substantial molecular and clinical heterogeneity. Within this subgroup, presence of FLT3 (FMS-like tyrosine kinase 3) internal tandem duplication (ITD) mutation predicts less favorable outcome. The goal of our study was to discover geneexpression patterns correlated with FLT3I...

Journal: :Blood 2002
Lee-Yung Shih Chein-Fuang Huang Jin-Hou Wu Tung-Liang Lin Po Dunn Po-Nan Wang Ming-Chung Kuo Chang-Liang Lai Hui-Chin Hsu

Analysis of internal tandem duplications of FLT3 (FLT3/ITD) was performed on bone marrow samples obtained at diagnosis and relapse from 108 adult patients with de novo acute myeloid leukemia (AML) to determine the role of this mutation in leukemic relapse. Eighty-three patients had wild-type FLT3 at both diagnosis and relapse, 16 had FLT3/ITD at both stages, whereas 8 had acquired the mutation ...

2013
J How J Sykes M D Minden V Gupta K W L Yee A D Schimmer A C Schuh S Kamel-Reid J M Brandwein

Internal tandem duplication of the fms-like tyrosine kinase-3 gene (FLT3-ITD) and nucleophosmin-1 (NPM1) mutations have prognostic importance in acute myeloid leukemia (AML) patients with intermediate-risk karyotype at diagnosis, but less is known about their utility to predict outcomes at relapse. We retrospectively analysed outcomes of 70 patients with relapsed, intermediate-risk karyotype AM...

Journal: :Blood 2016
Shaoguang Li

In this issue of Blood, Dany et al demonstrate a critical role of the ceramideregulated signaling pathway in inducing mitophagy to cause cell death and overcome drug resistance of acute myeloid leukemia (AML) cells carrying internal tandem duplication (ITD) of the Fms-like tyrosine kinase 3 (FLT3) gene. Inhibition of FLT3-ITD signaling through altering ceramide-involved lipid metabolism provide...

2016
Adhra Al-Mawali David Gillis Ian Lewis

BACKGROUND Acute myeloid leukemia (AML) is a heterogeneous clonal disorder presenting with accumulation of proliferating undifferentiated blasts. Xenograft transplantation studies have demonstrated a rare population of leukemia-initiating cells called leukemic stem cells (LSCs) capable of propagating leukemia that are enriched in the CD34+/CD38- fraction. LSCs are quiescent, resistant to chemot...

2014
Ghaleb Elyamany Mohammad Awad Kamal Fadalla Mohamed Albalawi Mohammad Al Shahrani Abdulaziz Al Abdulaaly

The Fms-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase that plays a key role in cell survival, proliferation, and differentiation of hematopoietic stem cells. Mutations of FLT3 were first described in 1997 and account for the most frequent molecular mutations in acute myeloid leukemia (AML). AML patients with FLT3 internal tandem duplication (ITD) mutations have poor cure rates the...

Journal: :Blood 2015
Manoj Garg Yasunobu Nagata Deepika Kanojia Anand Mayakonda Kenichi Yoshida Sreya Haridas Keloth Zhi Jiang Zang Yusuke Okuno Yuichi Shiraishi Kenichi Chiba Hiroko Tanaka Satoru Miyano Ling-Wen Ding Tamara Alpermann Qiao-Yang Sun De-Chen Lin Wenwen Chien Vikas Madan Li-Zhen Liu Kar-Tong Tan Abhishek Sampath Subhashree Venkatesan Koiti Inokuchi Satoshi Wakita Hiroki Yamaguchi Wee Joo Chng Shirley-Kow Yin Kham Allen Eng-Juh Yeoh Masashi Sanada Joanna Schiller Karl-Anton Kreuzer Steven M Kornblau Hagop M Kantarjian Torsten Haferlach Michael Lill Ming-Chung Kuo Lee-Yung Shih Igor-Wolfgang Blau Olga Blau Henry Yang Seishi Ogawa H Phillip Koeffler

Acute myeloid leukemia (AML) with an FLT3 internal tandem duplication (FLT3-ITD) mutation is an aggressive hematologic malignancy with a grave prognosis. To identify the mutational spectrum associated with relapse, whole-exome sequencing was performed on 13 matched diagnosis, relapse, and remission trios followed by targeted sequencing of 299 genes in 67 FLT3-ITD patients. The FLT3-ITD genome h...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید